Takara Good Will from 2010 to 2026

TF2 Stock  EUR 6.10  0.25  4.27%   
Takara Bio's Good Will is increasing over the last several years with slightly volatile swings. Good Will is predicted to flatten to about 5.6 B. Good Will is an intangible asset that arises when Takara Bio acquires another business for more than the fair market value of its net identifiable assets, representing the value of the brand, customer base, and other intangible factors. View All Fundamentals
 
Good Will  
First Reported
2016-12-31
Previous Quarter
6.5 B
Current Value
12.1 B
Quarterly Volatility
1.8 B
 
Covid
 
Interest Hikes
Check Takara Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Takara Bio's main balance sheet or income statement drivers, such as Interest Expense of 24.1 M, Selling General Administrative of 601.1 M or Total Revenue of 45.1 B, as well as many indicators such as . Takara financial statements analysis is a perfect complement when working with Takara Bio Valuation or Volatility modules.
  
This module can also supplement various Takara Bio Technical models . Check out the analysis of Takara Bio Correlation against competitors.
The Good Will trend for Takara Bio offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Takara Bio is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Takara Bio's Good Will Growth Pattern

Below is the plot of the Good Will of Takara Bio over the last few years. It is an intangible asset that arises when a company acquires another business for more than the fair market value of its net identifiable assets, representing the value of the brand, customer base, and other intangible factors. Takara Bio's Good Will historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Takara Bio's overall financial position and show how it may be relating to other accounts over time.
Good Will10 Years Trend
Slightly volatile
   Good Will   
       Timeline  

Takara Good Will Regression Statistics

Arithmetic Mean4,629,508,824
Geometric Mean3,644,121,315
Coefficient Of Variation59.46
Mean Deviation2,565,242,561
Median6,149,000,000
Standard Deviation2,752,854,859
Sample Variance7578209.9T
Range7B
R-Value0.78
Mean Square Error3226656.7T
R-Squared0.60
Significance0.0003
Slope422,560,784
Total Sum of Squares121251358T

Takara Good Will History

20265.6 B
20257.5 B
20246.5 B
20236.5 B
20226.7 B
20216.3 B
20206.1 B

About Takara Bio Financial Statements

Takara Bio stakeholders use historical fundamental indicators, such as Takara Bio's Good Will, to determine how well the company is positioned to perform in the future. Although Takara Bio investors may analyze each financial statement separately, they are all interrelated. For example, changes in Takara Bio's assets and liabilities are reflected in the revenues and expenses on Takara Bio's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Takara Bio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Good Will7.5 B5.6 B

Currently Active Assets on Macroaxis

Other Information on Investing in Takara Stock

Takara Bio financial ratios help investors to determine whether Takara Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Takara with respect to the benefits of owning Takara Bio security.